Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Gastroesophageal Junction Carcinoma · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Malignant Digestive System Neoplasm
Digestive System Carcinoma
Esophageal and Gastroesophageal Junction Carcinoma
Gastroesophageal Junction Carcinoma

Subtype

Gastroesophageal Junction Carcinoma

CI-CAN-00005404Explore in graph →

231 active trials9 approved drugs25 evidence items

NCIt: C203675

Overview
Statistics
Survival
Genomics19
Variants & evidence25
Drugs16
Trials706
Research
Rankings
Sources & provenance

Data completeness5 / 7 dimensions

Epidemiology (no data yet)
Survival (no data yet)
Trials (data present)
Literature (data present)
Genomics (data present)
Evidence (data present)
Therapies (data present)

Computed from entity_counters.completeness · refreshed after each connector run

Definition

What this entity is

A carcinoma that arises from the gastroesophageal junction. The vast majority of cases are adenocarcinomas. Rare cases are neuroendocrine carcinomas.

Definition text as published by ncit-evsProvenance

Source: NCI Thesaurus (NCIt)
Dataset: NCI Thesaurus
Version: 26.08e
Retrieved: Sep 8, 2026
Layer: raw (as published)
Evidence: expert curation
License: CC BY 4.0
Run: ING-NCITEVS-20260908-000001

Open at source Curated

Data updated 22 days agoSource updated 26.08e

Taxonomy

Position in the hierarchies

Several hierarchies coexist; edges are listed per hierarchy type with their source.

Parents

ncit

Esophageal and Gastroesophageal Junction CarcinomaSubtype

Children (2)

ncit

Gastroesophageal Junction Adenocarcinoma7 sub
Gastroesophageal Junction Neuroendocrine Carcinoma2 sub

54 descendants in total; counters on this page aggregate over all of them.

Anatomy

Anatomical sites

Digestive SystemC3052

Record

Identity

CancerIndex ID: CI-CAN-00005404
Entity type: Subtype
Malignant: Yes
Solid / hematologic: Solid tumor
Pediatric relevant: Not flagged
Rare cancer: Unknown (no incidence data yet)
Hierarchy depth: 6
Classification version: 26.08e
Semantic types: Neoplastic Process
Status: Active
Record updated: 2026-09-08

Coverage

Data completeness

Trials (all / active)

706 / 231

Publications (all / 5y)

166 / 61

Evidence items

25

Genes / variants

384 / 20

Drugs (any / approved)

16 / 9

Genomic cohorts

19

Epidemiology / survival obs.

0 / 0

Data updated 18 hours agoSource updated unknowncounters aggregate over descendants

Names

Synonyms (1)

Esophagogastric Junction Carcinomasynonym · NCIt

CancerIndex is a research and information platform. It does not diagnose and does not recommend treatment.

Key figures

At a glance

Each figure carries its unit, period and source; ranks link to "Why this rank?".

No registry-level ancestor: burden figures are published for the mutually exclusive top-level site groups only, and this entity does not descend from one. Global figures (IARC / GLOBOCAN) stay under license review and SEER awaits credentials.

Active trials231countcurrent registry status · entity + descendantsclinicaltrialsComputedrank #130 of 1,654 (World · both sexes · all ages · latest · all malignant entities)
Recruiting trials125countstatus RECRUITING · entity + descendantsclinicaltrialsComputedrank #129 of 1,277 (World · both sexes · all ages · latest · all malignant entities)
Curated evidence items25countaccepted CIViC items · entity + descendantscivicComputedrank #128 of 492 (World · both sexes · all ages · latest · all malignant entities)
Publications, last 12 months13countPubMed records · stored query · 12-month windowpubmedComputedrank #881 of 2,294 (World · both sexes · all ages · latest · all malignant entities)
Genomic cohorts19countopen GDC projects · entity + descendantsgdcComputedrank #66 of 296 (World · both sexes · all ages · latest · all malignant entities)

Data updated 18 hours agoSource updated unknownregistry figures: none · counters aggregate over descendants